SUBSCRIBE
SUBSCRIBE
News   Deals

Possible Schering-Plough Corporation , Kos Pharmaceuticals Merger Seen As Compelling

March 10, 2006 | 
1 min read

A possible acquisition of Kos Pharmaceuticals could be the solution to Schering-Plough’s lack of a high-density lipoprotien cholesterol drug, according to Prudential Equity Group.

Mergers & acquisitions
MORE ON THIS TOPIC
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
Strong Business Partnership and teamwork metaphor as two different groups joining together with a handshake represented by trees and stronk roots.
Deals
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal
June 26, 2025
 · 
1 min read
 · 
Annalee Armstrong
World heart day. Sketch style human heart. Retro halftone hands reaching out to each other. Modern collage. Valentines day banner. Healthcare medical concept. Healthy lifestyle.
Cardiovascular disease
Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact
June 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Passenger plane takes off from runway. Air transport, vector illustration
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
June 24, 2025
 · 
1 min read
 · 
Annalee Armstrong